Biotech and Pharmaceutical Industry News
April 19, 2024
Vita 34 AG
Vita 34 closes 2023 with significantly better results than expected based on preliminary figures
View Article
April 19, 2024
aap Implantate AG
aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights
View Article
April 19, 2024
Biophytis
Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
View Article
April 18, 2024
PharmaSGP Holding SE
PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023
View Article
April 18, 2024
Volta Medical SAS
Volta Medical Announces Late-Breaking TAILORED-AF Randomized Clinical Trial Results at Heart Rhythm 2024 in Boston, MA, USA
View Article
April 18, 2024
Evotec SE
Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments
View Article
April 18, 2024
CureVac
CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024
View Article
April 18, 2024
M1 Kliniken AG
M1 Kliniken AG publishes preliminary figures for financial year 2023: M1 continues to grow - sales growth of over 10% to € 316,3 million; EBIT increases by 68% to € 15.7 million
View Article
April 18, 2024
Straumann Holding AG
Invitation: Straumann Group 2024 first-quarter sales report webcast
View Article
April 18, 2024
Biophytis
Biophytis announces new Scientific Advisory Board for its phase 2 OBA clinical study in obesity
View Article
April 18, 2024
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech publishes unaudited first quarter results for 2024
View Article
April 18, 2024
DocMorris AG
DocMorris successfully completes the placement of CHF 200 million Convertible Bonds due 2029
View Article
April 17, 2024
Lonza Group AG
Lonza Prices EUR 1 Billion Straight Bond with a 3.875% Coupon
View Article